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Caffeine Timing Improves
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Grant M. Tinsley 2 , Kazimierz Surowiec 3 , Andrew R. Jagim 4 , Scott R. Richmond 1 and
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Little is known about the optimal time to consume caffeine prior to exercise to maximize
the ergogenic benefits of the substance.
Edited by:
Gustavo R. Mota,
Federal University of Triângulo
Mineiro, Brazil

Purpose: To determine the optimal pre-exercise time interval to consume caffeine
to improve lower-body muscular performance. A secondary aim was to identify the
presence of any sex differences in responses to timed caffeine administration.

Reviewed by:
Juan José Salinero,
Camilo José Cela University, Spain
Paulo Henrique Silva Marques
Azevedo,
Federal University of São Paulo, Brazil

Methods: Healthy, resistance-trained males (n = 18; Mean±SD; Age: 25.1 ± 5.7 years;
Height: 178.4 ± 7.1 cm; Body mass: 91.3 ± 13.5 kg; Percent body fat: 20.7 ± 5.2;
Average caffeine consumption: 146.6 ± 100.3 mg/day) and females (n = 11; Mean ±
SD; Age: 20.1 ± 1.6 years; Height: 165.0 ± 8.8 cm; Body mass: 65.8 ± 10.0 kg; Percent
bodyfat: 25.8 ± 4.2; Average caffeine consumption: 111.8 ± 91.7 mg/day) participated in
this investigation. In a randomized, double-blind, placebo-controlled, crossover fashion,
participants consumed 6 mg·kg−1 caffeine or placebo solution at three time points: 2 h
prior (2H), 1 h prior (1H), or 30 min prior (30M) to exercise testing. During three visits,
caffeine was randomly administered at one time point, and placebo was administered at
the other two time points. During one visit, placebo was administered at all three time
points. Next, participants performed isometric mid-thigh pulls (IMTP), countermovement
vertical jumps (CMVJ), and isometric/isokinetic knee extensor testing (ISO/ISOK).
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Results: Caffeine administered at 1H significantly improved absolute CMVJ and ISO
performance relative to placebo. Mean CMVJ jump height was significantly higher during
1H compared to 30M. However, only caffeine administered at 30M significantly improved
absolute measures of isokinetic performance. Analysis of the pooled caffeine conditions
revealed that muscular performance was more consistently augmented by caffeine in
males compared to females.
Conclusions: Pre-exercise caffeine timing significantly modulated participant responses
to the substance, with 1H exerting the most consistent ergogenic benefits relative to
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other time points, particularly compared to 2H. Male participants were found to respond
more consistently to caffeine compared to female participants. These results suggest
that active individuals can maximize the ergogenic effects of caffeine by consuming the
substance ∼1 h prior to the point when peak muscular performance is desired.
Keywords: caffeine, performance, nutrient timing, strength, power

INTRODUCTION

aqueous caffeine, Cmax values have been observed 15–150 min
post-consumption in subjects who consumed identical caffeine
solutions (32, 33, 35). It is important to note that more rapid
absorption merely results in a quicker onset of the effects of
caffeine, but not necessarily their magnitude (36). In addition,
variations in absorption kinetics have been attributed to
differences in dosage (33), mode of caffeine administration
(34, 36), dietary factors (37), and rate of gastric emptying (38).
Regardless, because of the typical pharmacokinetic profile of
caffeine, most researchers administer caffeine ∼1 h prior to
exercise testing (31, 39). However, such an approach may prevent
research participants from undergoing exercise testing when
plasma caffeine concentration is still increasing or near its peak.
In addition, different forms of administration can greatly impact
the time required to reach peak plasma caffeine concentrations,
further complicating attempts to coincide Cmax with the start of
exercise testing (36).
To date, several investigations (30–32, 40) examining the
impact of timed caffeine administration on endurance exercise
performance have produced somewhat conflicting results. Bell
and McLellan (30) first investigated the impact of caffeine
timing in active, endurance-trained participants. The researchers
administered either 5 mg·kg−1 body mass caffeine or placebo
solution to the participants at 6, 3, and 1h prior to a cycle timeto-exhaustion (TTE) test at 80% maximal oxygen consumption
(VO2 max) and reported that TTE was significantly improved
by all supplement conditions in caffeine non-users (defined as
those who ingested <50 mg·day−1 ). However, regular caffeine
users who typically ingested more than 300 mg caffeine only
experienced appreciable performance benefits when caffeine was
consumed either 1 or 3 h prior to exercise testing. A later
study conducted by Ryan and colleagues (31) examined the
impact of timed administration of caffeinated chewing gum on
cycle time-trial performance in trained male cyclists who were
moderate caffeine users (defined as ingesting <300 mg·day−1 ).
In a crossover manner, the participants chewed caffeinated gum
(containing 300 mg caffeine) at 120, 60, and 5-min time points
prior to 15 min of cycling at 75% VO2 max followed by a maximal
7 kJ·kg−1 cycle time-trial. The researchers reported that cycle
time-trial performance was only enhanced when the caffeinated
gum was administered 5 min before exercise. However, these
results were in contrast to an earlier investigation by the same
group (40), which found no effect of timed 200 mg caffeine
gum administration (35 min before, 5 min before, or 15 min after
exercise) on cycle TTE at 85% VO2 max in physically-active males
who were moderate caffeine users. Finally, Skinner et al. (32)
found that well-trained subjects (VO2 max > 60 mL·kg−1 ·min−1 )
who consumed 6 mg·kg−1 body mass caffeine 1 h prior to a

Caffeine (1,3,7-trimethylxanthine) is a commonly-consumed
nutraceutical that has been shown to acutely improve the
performance of endurance and resistance-based exercises (1–3).
The ergogenic effects of caffeine have largely been attributed to its
function as an adenosine receptor antagonist (4), as consumption
has been shown to increase motor activity, neuromuscular
coordination, and physiological arousal (5, 6). While much of
the original research involving caffeine employed endurance
models, a wide assortment of investigations have recently
demonstrated that the consumption of caffeine in doses ranging
from 3 to 9 mg·kg−1 body mass increases maximal isokinetic
torque production (7, 8), isotonic force production (9, 10),
muscular endurance (11–14), and power production (15–19)
in active individuals. However, several investigations have also
shown that acute caffeine consumption may exert little to no
effect on the aforementioned parameters (11, 20–23), suggesting
that substantial inter-individual variation exists in ergogenic
responses to its ingestion. For example, several investigations
failed to show significant mean differences in performance
between caffeine and placebo, but reported the presence of
a group of “responders” in the sample whose performance
significantly benefited from ingestion of the substance (11, 15,
24, 25). Thus, it is possible that the inter-individual variation in
responses to caffeine may result in non-significant differences in
mean exercise performance when measured a limited number
of times in a research setting, even though caffeine may be
highly ergogenic for some participants (26). Indeed, a recent
investigation (27) which compared the performance effects
of caffeine relative to placebo on eight different occasions
showed that even so-called ‘non-responders’ experienced mild
but detectable ergogenic effects following multiple bouts of
performance testing. Caffeine habituation and the presence of
certain genotype variations have been proposed as potential
factors influencing the inter-individual variation in the response
to caffeine and ergogenic outcomes (28, 29).
Another potential factor that may influence caffeine
ergogenicity is the timing of caffeine administration prior to
exercise testing, as previous investigators have suggested that
the ergogenic effect of caffeine is maximized when peak plasma
caffeine concentration coincides with the onset of physical
activity (30) or when plasma caffeine concentration is still
increasing during exercise (31, 32). Following ingestion, caffeine
is completely absorbed in the stomach and small intestine, with
plasma caffeine concentration increasing in a dose-dependent
manner (33, 34). Though peak plasma caffeine concentration
(Cmax ) is typically reached within 30–60 min of oral ingestion of
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during the 2 days before all remaining study visits. Upon arrival
to the laboratory for each testing session, participants completed
a brief customized sleep status questionnaire, consumed a
standardized meal, and donated a venous blood sample to allow
for baseline assessment of plasma caffeine content. Following
the baseline blood sample and at three designated time points,
participants consumed solutions containing either caffeine (6
mg·kg−1 of body mass) or placebo (maltodextrin) at 120, 60, and
30 min prior to exercise testing, in randomized order. During the
three experimental conditions, participants consumed caffeine at
a single pre-determined time point and placebo at all other time
points. During the placebo condition, a placebo was consumed
at all three ingestion points. Between the consumption of each
supplement solution, the participants remained seated and were
allowed to read, talk, or use technology. Following supplement
consumption and 10 min prior to performance testing, a
second blood sample was collected to assess pre-exercise plasma
caffeine concentration. Immediately after their second blood
collection, a 5-min standardized warmup was completed and
participants then completed an isometric mid-thigh pull test,
countermovement vertical jumps, an isometric knee extension
test using an isokinetic dynamometer, and an isokinetic knee
extensor fatigue protocol using an isokinetic dynamometer.
Within 5 min of completing exercise testing, a third venous
blood sample was collected to determine post-exercise plasma
caffeine concentration. Total testing time was ∼20 min.

40 km cycle time-trial completed the time-trial significantly faster
relative to placebo. However, when an identical pre-exercise dose
of caffeine was consumed at an individualized, pre-exercise time
point which would evoke peak plasma caffeine concentration at
the start of exercise, significant performance improvements were
not identified.
More information is needed regarding the optimal time to
administer caffeine prior to exercise, particularly as no studies
have been conducted to examine the effect of timed caffeine
administration on maximal force production, power production,
and muscular endurance. The identification of an optimal time
interval to consume caffeine prior to resistance exercise has
significant implications for active individuals, practitioners, and
the dietary supplement industry, as a wide array of products
and drinks containing caffeine are marketed to be consumed
before exercise (41, 42). In addition, limited information is
available regarding the effects of caffeine supplementation in
female participants, though preliminary information suggests
that males and females experience similar effects following acute
consumption (43). Thus, the purpose of this investigation was
to examine the effects of three pre-exercise caffeine timing
strategies on force production, power production, and muscular
endurance in a cohort of resistance-trained males and females.
A secondary aim of this study was to identify the presence of
any sex differences in responses to timed caffeine administration.
It was hypothesized that all caffeine conditions would improve
performance, but that caffeine administered 1 h prior to exercise
would result in the greatest performance benefit compared
to caffeine administered at other time points. It was also
hypothesized that performance outcomes would be similar
between men and women.

Subjects
Healthy, resistance-trained males [n = 18; Mean ± SD (Range);
Age: 25.1 ± 5.7 years; Height: 178.4 ± 7.1 cm; Body mass:
91.3 ± 13.5 kg; Percent body fat: 20.7 ± 5.2% fat; Average
absolute caffeine consumption: 146.6 ± 100.3 mg·day−1 (0–282
mg·day−1 ); Average relative caffeine consumption: 1.6 ± 1.1
mg·kg body mass−1 ·day−1 (0–3.7 mg·kg body mass−1 ·day−1 )]
and females [n = 11; Mean ± SD (Range); Age: 20.1 ± 1.6
years; Height: 165.0 ± 8.8 cm; Body mass: 65.8 ± 10.0 kg; Percent
bodyfat: 25.8 ± 4.2 % fat; Average absolute caffeine consumption:
111.8 ± 91.7 mg·day−1 (0–300 mg·day−1 ); Average relative
caffeine consumption: 1.8 ± 1.5 mg·kg body mass−1 ·day−1 (0–
4.7 mg·kg body mass−1 ·day−1 )] were recruited to participate
in this study. All participants reported at least 6 months of
structured resistance-training experience and had engaged in
resistance training at least twice per week for at least 45 min per
session at the time of enrollment in the study. Participants were
excluded if they consumed more than 300 mg caffeine per day,
were not between 18 and 45 years of age, or were currently being
treated for any metabolic, cardiac, musculoskeletal, pulmonary,
renal, immunological, psychological, or metabolic disease or
taking any medications (prescription or over-the-counter) that
might influence the physiological responses to caffeine or
resistance exercise at the time of enrollment. In addition,
current tobacco users and those who could not fit on testing
equipment were excluded from participation. All participants
reported habitual caffeine consumption <300 mg·day−1 via
completion of a brief, customized caffeine habits questionnaire
and were instructed to maintain their supplementation, dietary,
and training regimens throughout the study protocol. Finally,

MATERIALS AND METHODS
Experimental Overview
This randomized, double-blind, placebo-controlled, crossover
study consisted of five visits to the laboratory. Following
completion of an Institutional Review Board-approved
(Lindenwood University IRB-19-L0029, Approval date:
9/17/2018), written informed consent document, eligible
participants completed an initial familiarization session
consisting of a body composition assessment via dualenergy x-ray absorptiometry (DXA) and practice trials of
all performance tests, which included isometric mid-thigh
pulls, countermovement vertical jumps, and knee extensor
testing using an isokinetic dynamometer. Because participant
expectations of the effects of caffeine have been shown to
influence responses to the substance (44), a verbal explanation of
the effects of caffeine on muscular performance was provided to
participants at the end of the familiarization session. Following
the familiarization session, all participants completed four
identical testing sessions separated by at least 48 h (Figure 1).
Participants abstained from exercise, caffeine, and alcohol for
24 h and fasted from all calorie-containing foods and beverages
for at least 8 h prior to all five visits to the laboratory. In addition,
participants recorded their dietary intake for 48 h prior to their
second visit and were instructed to replicate their recorded intake
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FIGURE 1 | Experimental design. CMVJ, Counter-movement vertical jump; IMTP, Isometric mid-thigh pull; ISO, Isometric knee extensor assessment; ISOK, Isokinetic
knee extensor assessment; Min, minutes.

Supplementation Protocol

all female participants were required to confirm that they
were not pregnant or trying to become pregnant via written
questionnaire. All testing sessions for male participants were
separated by at least 48 h. Eumenorrheic and oligomenorrheic
female participants underwent their first testing session as close
as possible to 14 days after the start of their most recent
menstrual cycle, and follow-up testing sessions were scheduled in
1-week intervals following their initial visit. Amenorrheic female
participants were scheduled in 1-week intervals with no respect
to menstrual phase. Female participants who reported using oral
contraceptives or intrauterine devices were not excluded from
participation. In addition, it is important to note that caffeine
appears to have relatively similar ergogenic effects across different
phases of the menstrual cycle, as shown by Romero-Moraleda
et al. (45).

Over the course of this investigation, participants completed
all four supplemental conditions in a randomized, doubleblind, placebo-controlled, crossover manner. The order of the
supplemental conditions was determined using a computerized
random number generator (46). During each data collection
session, a solution of 175 mL water containing either caffeine or
placebo and flavored with a non-caloric sweetener (Crystal Light,
Kraft Foods, Inc., Chicago, IL) was provided to participants at
three time points: 120 min prior to exercise testing (2H), 60 min
prior to testing (1H), and 30 min prior to testing (30M). During
three of the sessions, a dose of anhydrous caffeine equivalent
to 6 mg·kg−1 body mass was administered at one time point
and placebo was administered at the other two time points.
For the placebo condition, placebo was administered at all
three time points. The caffeine was chosen to be administered
in liquid form due to the wide array of caffeinated drinks
(coffee, tea, soda, energy drinks) and powdered supplements
designed to be mixed with water (multi-ingredient pre-workout
supplements) that are commonly consumed by active individuals
to augment exercise performance (41, 47). To aid in blinding,
the pre-prepared caffeine conditions consisted of individual body
mass-specific doses of powdered anhydrous caffeine mixed with
∼3 g of pure maltodextrin powder (Carbo Gain, Now Foods,
Bloomingdale, IL) and were stored in sachets. Similarly, the
placebo sachets contained ∼4 g of maltodextrin powder, making
them visually identical to the caffeine sachets. Prior to each study
visit, the powdered supplemental conditions were mixed with
175 mL of water and ∼2.5 g of non-caloric sweetener until all
powder was completely dissolved. To prevent participants from
detecting differences in flavor between the placebo and caffeine
conditions, three different flavors of the non-caloric sweetener
were used during each visit, and one flavor was added to each
of the three drinks in a randomized fashion. Participants were
required to completely drink the supplement solution within
1 min of the specified time point. In addition, participants rinsed
the container the beverage was stored in and consumed the
remaining liquid to ensure that no residue was left behind.

Procedures
Anthropometric and Body Composition Assessments
All body composition and anthropometric measurements were
obtained during the initial familiarization session. Body mass
was determined using a digital balance (BWB-627A Class III,
Tanita Corp, Inc., Tokyo, Japan) and height was assessed
using a stadiometer (HR-200, Tanita Corp, Inc., Tokyo,
Japan). Body composition was determined via dual-energy
x-ray absorptiometry (DXA) (Hologic Discovery A, Hologic
Inc., Bedford, MA). Participants were positioned on the scan
table according to manufacturer instructions. All scans were
analyzed by the same trained researcher using the manufacturerprovided software package (Hologic APEX Version 4.5.3) and
the NHANES correction factor. The test-retest reliability of these
DXA procedures in our laboratory has been previously shown
to be excellent (ICC ≥ 0.996) using the same device and a
similar population.

Sleep Status and Blinding Questionnaires
During all testing sessions, participants completed a brief sleep
status questionnaire immediately upon arrival to the laboratory.
Participants reported how many hours of sleep they had the
night prior to the testing visit and rated their perceived sleep
quality on a scale from 0 to 10. In addition, the average amount
of sleep per night during the entire week prior to the testing
visit was reported. Following completion of each testing visit,
participants reported which supplement condition they thought
was administered to them during the visit and answered a single
question assessing the presence of acute caffeine withdrawal.

Frontiers in Nutrition | www.frontiersin.org

Dietary Intake Standardization
Participants recorded all calorie-containing foods and fluids
consumed during the 48 h prior to arriving for the first data
collection session. Each food log packet contained images and
instructions detailing how to accurately assess portion sizes
of foods and beverages. Following the initial testing session,
participants were provided a copy of the food log and instructed
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position. Vertical jump height was calculated using the time-inair method, according to the following equation. In this equation,
g is equal to 9.81 m·s−2 , t is equal to the time that the participant
was in the air while jumping from the force plates, and jump
height is expressed in meters.

to replicate their dietary intake during the 2 days preceding
each subsequent study visit. However, compliance with these
instructions was not tracked, which is a potential limitation of
our approach. Upon arrival to the laboratory for each testing
session, participants were provided with a small, standardized,
carbohydrate-rich meal (170 kcal, 1.5 g fat, 40 g carbohydrate,
1 g protein) which was consumed 150 min prior to exercise
testing. This meal was provided to reduce gastrointestinal distress
resulting from consumption of caffeine following an overnight
fast. However, it is important to note that this meal may have
influenced participants’ rates of gastric emptying, resulting in
greater heterogeneity during the resultant performance tests.

t 2
Jump Height (m) = 1/2g( )
2
Participants completed all jumps with their hands on their
hips, as alterations in the center of gravity resulting from arm
swinging have been shown to dramatically increase vertical jump
performance (53). Peak jump height and average jump height of
the three trials were recorded.

Performance Testing
Isometric Mid-thigh Pull (IMTP) testing

Isometric and isokinetic knee extensor testing

Following a 5-min standardized warmup consisting of dynamic
bodyweight movements such as walking lunges, squats, and
leg swings, participants performed four exercise tests to assess
lower-body force production, power production, muscular
endurance, and fatigue resistance. Immediately after the warmup,
participants performed an isometric mid-thigh pull testing
protocol consisting of a single 5-s trial repetition followed by
three 5-s maximal pulls, with 30 s of rest between repetitions.
An adjustable-height horizontal handle was attached via chain
to a computerized load cell sampling at 150 Hz (iLoad Pro
Digital USB, Loadstar Sensors, Fremont, CA) to measure the peak
tensile force generated during each mid-thigh pull repetition. The
knurled handle was positioned approximately halfway between
the subjects’ patella and inguinal fold so that the body position
of the participants when gripping the handle at this height
closely resembled the start of the second pull phase of a barbell
clean (48). The height of the handle was recorded during
the familiarization session for each participant and replicated
during all testing sessions. Participants were verbally encouraged
to pull upward as hard and fast as possible, as this cue has
been demonstrated to result in optimal force production during
mid-thigh pull testing (49). A double-overhand grip was used
during all repetitions. Peak force production and average force
production of the three trials were recorded. Isometric midthigh pull assessments have been shown to be strongly related to
athletic performance outcomes such as strength (48, 50), sprint
performance (50, 51), and agility performance (50). Importantly,
this type of test does not require the same level of technical skill
and has reduced risk of injury compared to dynamic tests of
maximal strength such as one-repetition maximum tests (52).

Following 5 min of rest, knee extensor testing was completed
using an isokinetic dynamometer (Biodex System 3, Biodex
Medical Systems, Shirley, NY). Participants were positioned
on the dynamometer in accordance with lower-body testing
procedures provided by the manufacturer. The axis of rotation
of the knee joint of the participants’ self-reported dominant
leg was aligned with the axis of the dynamometer unit and
the participant was secured using seat and leg restraints during
all testing procedures. Participant positioning was recorded
during the familiarization session and replicated during all study
visits. Following positioning and calibration of the dynamometer,
participants performed a maximal knee extension trial repetition
lasting 5 s. Next, three maximal voluntary contractions of 5 s
duration were performed by participants, with 30 s of rest
between each repetition. All isometric knee extension repetitions
were completed at an angle of 60◦ flexion below horizontal.
Peak isometric torque production and the average peak torque
production across the three repetitions were recorded.
After 5 min of rest, isokinetic knee extensor testing of
the dominant leg was completed using identical positioning
procedures according to the methods of Thorstensson and
Karlsson (54). Following the completion of five maximal trial
repetitions, participants performed 50 maximal knee extension
repetitions at 180◦ /s, extending from a flexed position (90◦ ) to a
fully extended knee angle (0◦ ). During the flexion phase of each
repetition, participants lowered their legs passively. This testing
protocol was completed in ∼50 s. Peak torque, average peak
torque, total work completed during the test, work completed
during the first third of the test, work completed during the last
third of the test, and work fatigue percentage were recorded.
Immediately following completion of the knee extensor testing
protocol, rating of perceived exertion (on a scale from 0 to 10)
and perceived muscular pain (on a scale from 0 to 10) were
collected by investigators.

Countermovement Vertical Jump (CMVJ) testing
Following 2 min of rest after the mid-thigh pull assessment, a
countermovement vertical jump testing protocol was completed.
Participants stood in a neutral athletic stance with each foot
positioned at shoulder width on a separate force platform
sampling at 1,000 Hz (PS-2141, Pasco, Roseville, CA). Following a
single trial repetition, each participant performed three maximaleffort countermovement vertical jumps with 10 s of rest in
between each attempt. Participants bent their knees to a partiallyflexed position, and without pausing, rapidly jumped upward as
high as possible before landing on the force plates in an athletic

Frontiers in Nutrition | www.frontiersin.org

Venipuncture and Plasma Caffeine Analysis
Venous blood samples were obtained from a forearm vein located
in the antecubital region using standard phlebotomy procedures
at three time points: 125 min prior to exercise testing, 10 min
before exercise, and immediately following exercise. All venous
blood samples were collected using heparinized vacutainer tubes
and centrifuged at 20◦ C for 10 min at 3,500 RPM. Plasma
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via Prism (Version 8.1.0, GraphPad Corp., San Diego, CA) and R
(R Core Team, Vienna, Austria).

samples were transferred into labeled microcentrifuge tubes and
frozen at −80 ◦ C for analysis of plasma caffeine concentrations.
Plasma caffeine levels were quantified via high-performance
liquid chromatography using the methods described by Alvi and
colleagues (55). Thermo Scientific Ultimate 3000 HPLC system
equipped with the Diode Array Detector and thermostated
column oven was used. Data acquisition was collected and
processed using Chromeleon software. Thermo Scientific column
Acclaim 120, C18 3 um 120 A 3 × 150 m mm at a flow
rate of 0.4 mL/min.

RESULTS
Sleep Status
A repeated measures ANOVA revealed no significant interaction
effect (p = 0.649) or significant main effects (p < 0.806) for
sleep duration during the night prior to testing. Similarly, the
interaction effect (p = 0.661) and main effects (p < 0.560) for
average sleep during the week prior to testing were not found
to be significant. However, a significant (p = 0.012) betweencondition difference in perceived sleep quality was detected using
a Friedman test. Post-hoc analysis was completed via multiple
Wilcoxon signed-rank tests, and a Bonferroni correction was
applied to control the familywise error rate. It was found that
perceived sleep quality during the 2H condition was significantly
lower than during 1H (Z = −2.655, p = 0.008).

Statistical Analyses
Descriptive statistics were calculated using standard statistical
methods. Shapiro–Wilk tests were employed to assess the
normality of all outcome measures. When data was identified as
skewed or non-normal, log10 transformations were completed.
When log10 transformations did not improve model assumptions
for non-normal data, non-transformed data was reported. The
presence of outliers in the raw data was examined using box
plots. An additional analysis was completed with all outliers
removed and no material changes in our reported outcomes
were identified. As a result, all outliers were retained. To
determine the combined effect of all caffeine conditions on
performance, caffeine conditions for the total sample and for each
sex were pooled and compared against the placebo condition
using paired samples t-tests. To determine the presence of any
main and interaction effects for sleep status as well as all absolute
performance outcomes, multiple 4 × 2 (supplement condition
by sex) ANOVAs were performed with condition as a withinsubjects factor and sex as a between-subjects factor. ANOVAs
with condition as a within-subjects factor were employed to
determine main effects and between-condition differences in
performance outcomes within each sex. A 4 × 3 (supplement
condition by time) repeated measures ANOVA was employed
to analyze plasma caffeine levels at each collected time point.
When the sphericity assumption was violated, GreenhouseGeisser corrections were applied. Partial eta squared (η2P ) was
calculated as SSEffect /(SSEffect + SSError ). These values can be
cautiously interpreted to denote small, medium, or large effects
when exceeding benchmarks of 0.0099, 0.0588, and 0.1379,
respectively (56). Differences in absolute ordinal data for each
sex and for the entire sample (Pain, Perceived sleep quality,
and RPE) were determined via Friedman tests, and post-hoc
comparisons of ordinal data were completed using Wilcoxon
signed rank tests. The Bonferroni correction was applied to all
pairwise comparisons to control the familywise error rate. Total
and sex-specific ordinal data from the three caffeine conditions
were pooled and compared against the placebo condition using
Wilcoxon Signed Rank tests. Effect sizes (Cohen’s d) were
calculated for all statistically-significant (p < 0.05) differences
between conditions and were interpreted as trivial (0–0.19), small
(0.20–0.49), medium (0.50–0.79) or large (0.80 or greater) (57).
For all statistical tests, a significance threshold of p < 0.05
was used. All analyses were completed using Microsoft Excel
2016 (Microsoft Corp., Redmond, WA) and IBM SPSS Statistics
(Version 25.0, IBM Corp., Armonk, NY). Figures were generated
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Performance Outcomes
Isometric Mid-thigh Pull Force Production (IMTP)
Repeated measures ANOVA revealed no differences in absolute
mean and peak IMTP performance for the total sample
and within both sexes (Table 1). Sex-specific response figures
comparing the percent change in IMTP performance from
baseline for each condition are depicted in Figure 2. Pairedsamples t-tests revealed that peak (p = 0.019; d = 0.21) and
mean (p = 0.015; d = 0.21) IMTP performance were significantly
greater than placebo in the pooled caffeine conditions for the
total sample. Peak (p = 0.011; d = 0.39) and mean (p =
0.008; d = 0.38) IMTP performance in the pooled caffeine
conditions were significantly greater than placebo in males. No
differences between the pooled caffeine conditions and placebo
were identified in females (p < 0.963).

Countermovement Vertical Jump Height (CMVJ)
Repeated measures ANOVA of the absolute performance results
of the total sample revealed that peak and mean CMVJ
performance were significantly improved relative to placebo by
all caffeine conditions, with 1H producing the greatest magnitude
of ergogenic effect for both outcomes, followed by 2H and
30M (Table 1). In addition, mean jump height during 1H was
found to be significantly higher than in the 30M condition for
the total sample. Repeated measures ANOVA of sex-specific
results revealed that peak jump height was significantly greater
than placebo in the 2 and 1H conditions for both males and
females, though a significant difference between 1H and 30M
was only detected in males. Similar results were observed for
mean jump height; caffeine administered at 2 and 1H improved
performance relative to placebo in both sexes. However, mean
CMVJ performance during 1H was significantly >30M in
males only, and performance during the 30M condition was
significantly greater than placebo in female participants only.
Sex-specific response figures comparing the percent change
in CMVJ performance from baseline for each condition are
depicted in Figure 3. Paired samples t-tests revealed that peak
(p < 0.001; d = 0.28) and mean (p = 0.001; d = 0.28)
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TABLE 1 | Influence of caffeine timing on performance outcomes.
Variable

Peak IMTP (N)

Mean IMTP (N)

Peak CMVJ
Jump height (m)

Mean CMVJ
jump height (m)

Isometric peak
torque (N·m)

Mean isometric
peak torque
(N·m)

Isokinetic peak
torque (N·m)

Mean isokinetic
peak torque
(N·m)

Total isokinetic
work (J)

Group

2 H (d)

1 H (d)

30 Min (d)

p-value (η2P )

Placebo
Condition

Sex

I

<0.001
(0.390)

0.096
(0.075)

<0.001
(0.407)

0.130
(0.067)

0.012
(0.211)

0.071
(0.091)

0.011
(0.215)

0.543
(0.024)

<0.001
(0.403)

0.485
(0.030)

<0.001
(0.381)

0.249
(0.049)

<0.001
(0.526)

0.422
(0.034)

<0.001
(0.506)

0.366
(0.038)

<0.001
(0.605)

0.821
(0.011)

Male

1,770.5 ± 411.4

1,772.5 ± 416.8

1,766.3 ± 448.5

1,621.9 ± 337.7

0.011
(0.195)

Female

1,177.0 ± 349.9

1,198.8 ± 242.6

1,151.4 ± 242.3

1,177.2 ± 337.9

0.707
(0.045)

Total

1,545.4 ± 482.0

1,554.9 ± 454.7

1,533.1 ± 485.1

1,453.2 ± 397.7

0.097
(0.075)

Male

1,669.7 ± 379.7

1,678.9 ± 395.8

1,652.1 ± 411.7

1,534.3 ± 313.8

0.010
(0.198)

Female

1,098.7 ± 307.7

1,119.5 ± 238.4

1,085.3 ± 225.1

1,098.7 ± 290.4

0.830
(0.029)

Total

1,453.1 ± 448.2

1,466.7 ± 437.8

1,437.1 ± 446.5

1,369.1 ± 369.1

0.077
(0.080)

Male

0.39 ± 0.09*(0.34)

0.39 ± 0.08* (0.30)

0.37 ± 0.08

0.36 ± 0.08

0.001
(0.348)

Female

0.30 ± 0.06* (0.32)

0.31 ± 0.06* (0.46)

0.31 ± 0.07

0.28 ± 0.06

0.033
(0.334)

Total

0.36 ± 0.09* (0.29)

0.360 ± 0.08* (0.31)

0.35 ± 0.08* (0.21)

0.33 ± 0.08

<0.001
(0.279)

Male

0.37 ± 0.08* (0.31)

0.38 ± 0.08* (0.34)

0.36 ± 0.08

0.35 ± 0.09

<0.001
(0.425)

Female

0.29 ± 0.06* (0.38)

0.30 ± 0.06* (0.50)

0.29 ± 0.06* (0.35)

0.27 ± 0.06

<0.001
(0.547)

Total

0.34 ± 0.08* (0.29)

0.35 ± 0.08* (0.35)

0.34 ± 0.08* (0.20)

0.32 ± 0.08

<0.001
(0.436)

Male

269.5 ± 78.6

270.3 ± 59.8* (0.37)

270.4 ± 65.2* (0.36)

247.6 ± 62.4

0.011
(0.195)

Female

169.5 ± 49.6

182.2 ± 42.8

173.9 ± 42.9

163.1 ± 37.9

0.040
(0.239)

Total

231.5 ± 84.0

236.9 ± 68.7* (0.31)

233.8 ± 74.2* (0.26)

215.5 ± 68.0

0.002
(0.162)

Male

256.5 ± 77.3

257.3 ± 58.3* (0.43)

257.8 ± 63.9* (0.41)

232.7 ± 55.7

0.001
(0.291)

Female

161.2 ± 49.2

175.4 ± 42.0

167.8 ± 41.0* (0.30)

155.8 ± 39.4

0.029
(0.257)

Total

220.3 ± 81.9

226.2 ± 65.8* (0.35)

223.6 ± 71.1* (0.30)

203.5 ± 62.3

<0.001
(0.225)

Male

191.8 ± 38.0

193.9 ± 39.3

193.0 ± 37.3

184.5 ± 36.3

0.029
(0.161)

Female

116.7 ± 32.8

123.5 ± 26.0

124.3 ± 25.8

117.4 ± 27.3

0.048
(0.229)

Total

163.3 ± 51.3

167.2 ± 48.9

167.0 ± 47.3* (0.17)

159.0 ± 46.5

0.006
(0.143)

Male

120.8 ± 25.0

121.9 ± 25.6

124.7 ± 26.5* (0.23)

118.7 ± 25.5

0.006
(0.214)

Female

74.7 ± 17.5

78.8 ± 14.4

78.9 ± 14.7

76.6 ± 14.8

0.193
(0.144)

Total

103.3 ± 31.74

105.5 ±30.4

107.3 ± 31.9* (0.14)

102.7 ± 30.1

0.006
(0.143)

Male

7,061.9 ± 1097.4

7,044.5 ± 1141.6

7,171.1 ± 1052.1

6,841.7 ± 984.3

0.07
(0.128)

Female

4,615.2 ± 914.3

4,763.3 ± 832.7

4,777.4 ± 891.0

4,548.8 ± 951.8

0.455
(0.082)

6,133.8 ± 1,577.8

6,179.2 ± 1,519.2

6,263.1 ± 1,533.8

5,972.0 ± 1,481.1

0.051
(0.091)

Total

†

†

†

(Continued)
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TABLE 1 | Continued
Variable

Isokinetic work
first third (J)

Isokinetic work
last third (J)

Group

1 H (d)

30 Min (d)

p-value (η2P )

Placebo
Condition

Sex

I

<0.001
(0.522)

0.420
(0.034)

<0.001
(0.547)

0.640
(0.020)

0.377
(0.029)

0.615
(0.022)

Male

3,341.3 ± 666.4

3,341.7 ± 626.5

3,398.5 ± 596.4* (0.51)

3,095.4 ± 587.4

0.004
(0.231)

Female

2,141.9 ± 531.9

2,221.5 ± 426.0

2,224.7 ± 476.1

2,089.3 ± 535.1

0.262
(0.126)

Total

2,886.3 ± 849.4

2,916.8 ± 780.5* (0.27)

2,953.3 ± 795.5* (0.31)

2,713.8 ± 747.4

0.004
(0.154)

Male

1,425.1 ± 278.7

1,426.7 ± 234.0

1,444.9 ± 221.4

1,500.7 ± 234.7

0.213
(0.084)

995.1 ± 165.6

1,023.0 ± 197.3

1,011.8 ± 182.1

1,018.6 ± 188.5

0.921
(0.016)

Total

1,262.0 ± 319.5

1,273.6 ± 294.8

1,280.6 ± 295.5

1,317.8 ± 320.6

0.437
(0.033)

Male

56.1 ± 10.8* (0.53)

56.6 ± 6.9* (0.67)

56.8 ± 6.8

50.0 ± 12.0

0.002
(0.244)

51.7 ± 10.5

53.3 ± 8.2

53.8 ± 6.6

49.4 ± 12.1

0.093
(0.190)

54.4 ± 10.7* (0.41)

55.3 ± 7.5* (0.56)

55.7 ± 6.8* (0.61)

49.8 ± 11.8

0.002
(0.189)

Female

Isokinetic work
fatigue (%)

2 H (d)

Female
Total

All data are presented as Mean ± Standard Deviation. P-values and measures of effect size (partial eta squared) are reported for all main effects (condition, sex) and interaction effects
(condition x sex) associated with each outcome. Effect sizes (Cohen’s d) are provided for all statistically-significant (p < 0.05) differences between conditions, as determined by Bonferroni
post-hoc analysis. All effect sizes are presented relative to the within-group (Male, Female, or Total) placebo trial. CMVJ, Countermovement vertical jump; I, Interaction Effect; IMTP,
Isometric mid-thigh pull; J, Joules; RPE, Rating of perceived exertion; m, meters; N, Newtons; N-m, Newton-meters; W, Watts; %, Percentage; η2P , Partial eta squared.
*Denotes significant within-group difference (p < 0.05) from placebo.
†

Denotes significant within-group difference (p < 0.05) from 30 Min.

FIGURE 2 | Effect of caffeine timing on isometric mid-thigh pull performance. 2H, 2Hours; 1H, 1Hour; 30M, 30 Minutes; IMTP, Isometric mid-thigh pull; %,
Percentage; 1, Delta. Line plots represent sex-specific group means and 95% confidence intervals for all delta values relative to the placebo value.

Isometric Knee Extensor Torque Production (ISO)

CMVJ jump height were significantly greater than placebo in
the pooled caffeine conditions for the total sample. Peak (p
= 0.001; d = 0.26) and mean (p < 0.001; d = 0.28) jump
height in the pooled caffeine conditions were significantly greater
than placebo in males. This pattern was mirrored in females;
peak (p < 0.001; d = 0.42) and mean (p < 0.001; d =
0.41) CMVJ performance were significantly augmented relative
to placebo.

Frontiers in Nutrition | www.frontiersin.org

Analysis of absolute performance data for the total sample
revealed that peak and average peak torque production were
significantly augmented relative to placebo during the 1H and
30M conditions, with the greatest magnitude of difference
observed during the 1H condition (Table 1). Sex differences in
absolute peak and absolute mean peak torque production were
also detected; caffeine administered at 1H and 30M significantly
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FIGURE 3 | Effect of caffeine timing on counter-movement vertical jump performance. 2H, 2 Hours; 1H, 1 Hour; 30M, 30 Minutes; CMVJ, Counter-movement vertical
jump; %, Percentage; 1, Delta. Line plots represent sex-specific group means and 95% confidence intervals for all delta values relative to the placebo value.

in the total sample and in males only. No differences in any
work variable were identified in the female participants. Work
fatigue percentage for the total sample was significantly higher
than placebo during all three caffeine conditions. Work fatigue
percentage was significantly greater than placebo in both the
2H and 1H conditions in males, while no between-condition
differences were detected for females.

improved peak and mean peak isometric knee extensor torque
in males. However, only mean peak torque production was
greater than placebo in females during the 30M condition. Sexspecific response figures comparing the percent change in ISO
performance from baseline for each condition are depicted in
Figure 4. Peak (p < 0.001; d = 0.26) and mean peak (p <
0.001; d = 0.30) isometric torque production for the total sample
were significantly greater than placebo in the pooled caffeine
conditions. Peak (p < 0.001; d = 0.35) and mean peak (p = 0.001;
d = 0.40) ISO performance in the pooled caffeine conditions were
significantly greater than placebo in males. Peak (p = 0.016; d =
0.30) and mean peak (p = 0.019; d = 0.30) ISO torque production
in the pooled caffeine condition were also significantly greater
than placebo in females.

Plasma Caffeine Concentration
Complete plasma caffeine concentration data was available
for 13 male and 10 female participants (Mean ± SD; Age:
21.9 ± 2.9 years; Height: 173.1 ± 10.8 cm; Body mass: 81.6
± 18.0 kg; Percent body fat: 23.4 ± 6.2%; Average caffeine
consumption: 124.0 ± 97.3 mg/day). Significant main (p <
0.001) and interaction (p < 0.001) effects were identified.
No significant between-condition differences in plasma caffeine
concentration were found at baseline (Figure 6). Pre-exercise
caffeine concentration was significantly higher in the 1H
condition (14.28 ± 1.36 µg·mL−1 ) relative to all other conditions
(p < 0.031). Post-exercise caffeine concentration was highest
in the 30M condition (14.54 ± 2.31 µg·mL−1 ), which was
significantly higher (p < 0.001) than the 2H condition (11.58 ±
1.88 µg·mL−1 ) and placebo (0.23 ± 0.34 µg·mL−1 ).

Isokinetic Knee Extensor Torque Production (ISOK)
Peak (p = 0.048; d = 0.15) but not mean peak (p = 0.455)
isokinetic torque was significantly augmented by the pooled
caffeine conditions in females. Absolute mean and mean peak
isokinetic performance for the total sample were only increased
relative to placebo in the 30M condition (Table 1). Analysis of the
absolute performance data for each sex revealed that only mean
isokinetic peak torque was significantly improved by the 30M
condition in males only. Sex-specific response figures comparing
the percent change in ISOK performance from baseline for each
condition are depicted in Figure 5. Peak (p = 0.001; d = 0.14) and
mean peak (p = 0.008; d = 0.09) isokinetic torque production
were significantly greater than placebo in the pooled caffeine
conditions for the total sample. Peak (p = 0.008; d = 0.23)
and mean peak (p = 0.01; d = 0.15) ISOK performance in the
pooled caffeine condition were significantly greater than placebo
in males.
No between-condition differences in total isokinetic work
were found for the total sample or for each sex. However,
isokinetic work completed during the first third of the test was
significantly augmented during the 1H and 30M conditions
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Subjective Responses
Wilcoxon signed rank tests revealed that subjective ratings of
RPE (Z = −2.221, p = 0.026) but not Pain (Z = −0.474,
p = 0.636) were significantly decreased relative to placebo in
the pooled caffeine condition for the total sample. RPE (Z =
−0.569, p = 0.569) and Pain (Z = −0.979, p = 0.328) were
not different from placebo in males. However, ratings of RPE (Z
= −2.288, p = 0.022) but not Pain (Z = −0.052, p = 0.959)
during the pooled caffeine conditions were significantly lower
than placebo in females. Friedman tests detected no significant
between-condition differences for absolute or delta RPE and Pain
ratings for the total sample, as well as within each sex.
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FIGURE 4 | Effect of caffeine timing on isometric knee extensor performance. 2H, 2 Hours; 1H, 1 Hour; 30M, 30 Minutes; ISO, Isometric knee extensor performance;
%, Percentage; 1, Delta. Line plots represent sex-specific group means and 95% confidence intervals for all delta values relative to the placebo value.

FIGURE 5 | Effect of caffeine timing on isokinetic knee extensor performance. 2H, 2 Hours; 1H, 1 Hour; 30M, 30 Minutes; ISOK, Isokinetic knee extensor
performance; %, Percentage; 1, Delta. Line plots represent sex-specific group means and 95% confidence intervals for all delta values relative to the placebo value.

Participants were able to correctly identify the supplement
condition they received during 64.7% of all testing visits. The
effectiveness of the blinding is in line with the results of a previous
investigation (60% correct identification) which employed an
identical dose of encapsulated caffeine (20). Six out of 29
participants reported the presence of perceived ergolytic caffeine
withdrawal symptoms during at least one testing visit. These
symptoms were reported during 6.9% of all visits, with 50%
occurring during the placebo condition.

this study indicate that, in the context of a laboratory setting,
acute caffeine supplementation improved lower-body force
production, power production, isometric torque production,
and isokinetic torque production in resistance-trained men and
women. Furthermore, the timing of caffeine administration
was found to significantly influence the ergogenic effects of
the substance, as caffeine consumed 1 h prior to exercise
testing produced the most consistent ergogenic effect across all
performance outcomes. Finally, divergent performance results
were identified between sexes, suggesting that resistance-trained
males and females may respond in different ways to acute
caffeine supplementation.
Analysis of the absolute performance data collected by this
investigation revealed that the timing of caffeine administration
significantly modulated the ergogenic effects of the substance.
Caffeine consumed 1 h prior to exercise improved absolute

DISCUSSION
The purpose of this investigation was to determine the optimal
pre-exercise time to consume caffeine to maximize muscular
performance and to identify any sex differences in caffeine
ergogenicity and responses to caffeine timing. The results of
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FIGURE 6 | Effect of caffeine timing on plasma caffeine concentration. 2H, 2 Hours; 1H, 1 Hour; 30M, 30 Minutes; B, Baseline Time Point; Pre, Pre-Exercise Time
Point; Post: Post-Exercise Time Point; P, Placebo; µg/mL, micrograms per milliliter. Center bars represent sex-specific group means.

note that only the 30M condition in the present investigation
resulted in significant improvements in absolute isokinetic
torque production. However, because the entire muscular
performance testing battery took ∼20 min to complete, the onset
of isokinetic testing occurred ∼45-50 min after ingestion of the
30M condition. Thus, it is possible that the results of isokinetic
testing more closely reflect the ergogenic effects of caffeine
administered 1 h prior to testing had the isokinetic test been
performed first in the testing protocol. These results suggest
that a more nuanced approach to pre-exercise caffeine timing
may allow for targeted improvement of exercise performance
during an extended training session or athletic competition.
In short, consuming caffeine ∼1 h before the exact time that
peak performance is desired may be a superior timing strategy
compared to consuming caffeine 1 h prior to the start of exercise
or competition.
Comparisons between the pooled caffeine condition and
placebo indicate that acute pre-exercise caffeine consumption
significantly improved lower-body force production, power
production, and muscular endurance in the resistance-trained
individuals recruited by this investigation. These findings
support the ergogenic utility of acute caffeine supplementation
and align with several earlier investigations which reported
significant increases in knee extensor isometric force production
(58, 59), isokinetic torque production (7, 8, 60–62), and total
isokinetic work completed (63) following the ingestion of
moderate doses of caffeine (5–7 mg·kg−1 ). In addition, the
effect sizes of the improvement in isometric (d = 0.24–0.30,
p < 0.001) and isokinetic (d = 0.09–0.14, p < 0.008) knee
extensor strength found in the pooled caffeine condition are
similar to the overall standardized mean difference (SMD) for the
caffeine-mediated improvement in knee extensor MVC strength
(SMD = 0.37, p = 0.0002) found by Warren et al. (64) in a

mean and peak CMVJ and ISO performance to a greater
degree than the other two supplement conditions, as indicated
by effect size analysis (Table 1). In addition, absolute mean
CMVJ jump height was significantly greater during the 1H
condition compared to 30M, further supporting the efficacy of
caffeine consumed 1 h prior to exercise testing compared to
other time points. Similarly, analysis of the subgroup of subjects
with complete plasma caffeine concentration data suggests that
peak pre-exercise plasma caffeine concentration was significantly
modulated by the timing protocols employed in the present
investigation. Based on these results, it appears that pre-exercise
plasma caffeine concentration is maximized by consuming
caffeine administered in liquid form 1 h prior to exercise.
However, post-exercise caffeine concentration was largest in the
30M condition, particularly compared to 2H and P. This general
pattern is mirrored by the performance data, suggesting that
caffeine timing strategies to improve performance should center
on maximizing plasma caffeine concentrations at either the start
of exercise or when peak performance is needed.
Though direct comparisons between the present investigation
and other caffeine timing studies are difficult due to differences
in exercise modality and mode of caffeine administration,
the identification of timing-related performance benefits in
the present sample mirrors the findings of several earlier
investigations, albeit with a different mode of exercise (30,
32). For example, Skinner et al. (32) noted that 6 mg·kg−1
caffeine in capsule form significantly improved 40 km cycle
time trial performance when administered 1 h prior to exercise
but had no ergogenic effect when administered at 120 or
150 min before testing. Similarly, Bell and McLellan (30) reported
that caffeine administered at 1 or 3H but not 6H prior
to exercise significantly improved performance during cycle
time-to-exhaustion testing in caffeine users. It is important to
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2010 meta-analysis as well as to the SMD (0.19, p = 0.004) for
isokinetic knee extensor strength reported by Grgic and Pickering
(65) in a 2019 meta-analysis. Similarly, the ergogenic benefit of
acute caffeine consumption on lower-body power production
demonstrated by this investigation mirror the results of Bloms
et al. (19), who reported a significant effect of acute caffeine
consumption (5 mg·kg−1 ) on countermovement jump height
in a mixed sex cohort of resistance-trained collegiate athletes.
The lack of any demonstrable effect of caffeine supplementation
on perceived pain during repeated isokinetic contractions also
reflects the results of several investigations (62, 66) which
found no effect of caffeine on perceived pain during isokinetic
knee extensor contractions at 180◦ ·s−1 . However, acute caffeine
supplementation significantly lowered participants’ subjective
rating of perceived exertion during isokinetic exercise, in
accordance with previous investigations (67). In addition, it is
important to note that a degree of inter-individual variability
in the responses to caffeine was observed in the present
investigation, which is particularly evident when examining the
confidence intervals of the figures displaying percent change
from placebo (Figures 2–5). These responses were retained in the
dataset because they represented true participant performance
responses. This determination was made after removing all of
them from the original analysis (with them included), which
resulted in the same statistical outcomes being identified as
when the outliers were included. The changes in these outcomes
could largely be explained by comparatively poor performance
in the placebo condition relative to the three experimental
conditions, or particularly excellent peak performance in one or
more conditions. These differences could potentially be caused
by differences in motivation, warm-up efficacy, motivation, selfeffort, and exercise execution between the four conditions. In
addition, other variables such as menstrual phase could have
impacted our results (68). However, all of these variables were
controlled, as stated in the methods section. It should be
emphasized that these figures showing percent change from
placebo are entirely intended for descriptive purposes, as all
analyses performed in the present investigation used absolute
performance data. Finally, to determine if potential outliers
resulting from variable performance data had any impact on
the conclusions of this investigation, a sensitivity analysis was
performed in which all outliers (measurements from 1 to 2
individual participants per outcome variable) were removed and
the data were re-analyzed. Following re-analysis with outliers
removed for each outcome variable, all main results were
unchanged, further supporting the conclusions made using the
original analytical approach.
The results of this investigation suggest the presence of
sex-specific differences in responses to caffeine, as muscular
performance was augmented more consistently after ingestion
of the substance in males compared to females (Table 1). In
addition, paired-samples t-tests showed that peak and mean
IMTP force production were significantly enhanced relative
to placebo in the pooled caffeine conditions for males, while
no differences relative to placebo were detected in females.
Finally, non-parametric analysis of the pooled caffeine conditions
revealed that RPE during isokinetic exercise was significantly
decreased by caffeine consumption in female participants only.
Frontiers in Nutrition | www.frontiersin.org

These results are particularly meaningful, as a limited number
of caffeine investigations have recruited female participants and
even fewer have examined sex-specific responses to caffeine in
a mixed-sex cohort (43). One possible explanation for the sexspecific responses observed in this investigation may be due to
the influence of sex hormones on gastric emptying, as several
investigations have shown that elevated levels of progesterone
result in slower rates of gastric emptying (69, 70). The presence of
sex-specific responses to caffeine aligns with the results observed
by Sabblah et al. (71), who administered caffeine (5 mg·kg−1 )
to resistance-trained males and females 1 h prior to bench
press one-repetition maximum (1RM) testing and bench press
repetitions to fatigue at 40% 1RM. Though only a trend (p =
0.059) was detected for total weight lifted (TWL) during the
muscular endurance test, males increased TWL by ∼24% while
the TWL by females did not appreciably change (<1% change).
The authors concluded that the female participants’ response to
caffeine was of lesser magnitude than male participants, which
aligns with the results of the present investigation. However, it is
important to note that Sabblah et al. (71) employed a single-blind
study design and did not attempt to control for menstrual phase,
thus limiting the generalizability of their results.
In conclusion, the present investigation revealed for the first
time that pre-exercise caffeine timing significantly modulated
the ergogenic impact of the substance on lower-body muscular
performance, identified significant differences in responses to
acute caffeine supplementation between sexes, and further
supported the utility of acute caffeine consumption to improve
lower-body muscular performance. Based on the results of this
study, it appears that caffeine consumed 1 h prior to exercise
exerts the most consistent ergogenic benefits relative to other
time points. However, those seeking to improve lower-body
muscular performance during extended training sessions or
competitions should consume caffeine ∼1 h prior to the time
when peak performance is most needed, rather than 1 h prior
to the start of exercise/competition. These results apply to a
wide variety of active individuals who consume caffeine prior to
resistance exercise or prior to activities which require lower-body
force and power production. Additional research is needed to
determine the effect of caffeine timing on upper-body muscular
performance as well as sport-specific performance in other
populations. Future research should also investigate the impact
of caffeine timing using lower doses of caffeine, multiple doses
for longer-duration bouts of exercise, other forms of caffeine
administration, as well as potential genetic influences on optimal
caffeine timing.
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